United States
Germany
Japan
United Kingdom
China
CRYZL1 mouse monoclonal antibody, clone OTI2F9 (formerly 2F9)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Antibodies
CRYZL1 mouse monoclonal antibody, clone OTI2C3 (formerly 2C3)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CRYZL1 mouse monoclonal antibody, clone OTI2F9 (formerly 2F9)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
CRYZL1 mouse monoclonal antibody, clone OTI1H11 (formerly 1H11)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
CRYZL1 mouse monoclonal antibody, clone OTI1C9 (formerly 1C9)
| Applications | FC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CRYZL1 mouse monoclonal antibody, clone OTI1B3 (formerly 1B3)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
CRYZL1 mouse monoclonal antibody, clone OTI1D9 (formerly 1D9)
| Applications | FC, WB |
| Reactivities | Human, Dog, Rat, Mouse |
CRYZL1 mouse monoclonal antibody, clone OTI1A3 (formerly 1A3)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
CRYZL1 mouse monoclonal antibody, clone OTI2C3 (formerly 2C3)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CRYZL1 mouse monoclonal antibody, clone OTI1H11 (formerly 1H11)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
CRYZL1 mouse monoclonal antibody, clone OTI1D9 (formerly 1D9)
| Applications | FC, WB |
| Reactivities | Human, Dog, Rat, Mouse |
CRYZL1 mouse monoclonal antibody, clone OTI1C9 (formerly 1C9)
| Applications | FC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CRYZL1 mouse monoclonal antibody, clone OTI1B3 (formerly 1B3)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
CRYZL1 mouse monoclonal antibody, clone OTI1A3 (formerly 1A3)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
